Search research articles
Contact Us
Filters
Showing results (1-10 of 68) with videos related to
Page
of 7
Sort By:
Journal of General Internal Medicine
|
May 24, 2015
Capsule Commentary on Duru et al., Adherence to Metformin, Statins, and ACE/ARBs Within the Diabetes Health Plan (DHP)
R Brett McQueen
Pharmacoeconomics
|
May 16, 2020
What Value Does the NCCN Affordability Rating Really Provide to Patients, Providers, and Society?
R Brett McQueen
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 15, 2025
Should Early-Stage NIH Funding Influence Pharmaceutical Drug Pricing?
William V Padula, R Brett McQueen
Applied Health Economics and Health Policy
|
October 6, 2019
Expanding the Role of the Patient-Centered Outcomes Research Institute: Reauthorization and Facilitating Value Assessments
William V Padula, R Brett McQueen
Pharmacoeconomics
|
March 24, 2021
Toward Modified Impact Inventory Tables to Facilitate Patient-Centered Value Assessment
R Brett McQueen, Julia F Slejko
Pharmacotherapy
|
March 8, 2013
Clinical and financial impact of pharmacy services in the intensive care unit: pharmacist and prescriber perceptions
Robert MacLaren, R Brett McQueen, Jon Campbell
Diabetes Care
|
February 20, 2026
Deep Learning-Enabled Diabetic Retinopathy Screening: A Techno-Clinical Revolution or Just More Artificial Intelligence Hype?
Darpit Dave, Steven R Steinhubl, R Brett McQueen
Journal of Managed Care & Specialty Pharmacy
|
January 19, 2024
Assessing clinical benefit in the Medicare Drug Price Negotiation Program: A 2-step approach for improving transparency, consistency, and meaningful patient engagement
Michael J DiStefano, Antal Zemplenyi, R Brett McQueen
Annals of the American Thoracic Society
|
February 25, 2014
The "e" in cost-effectiveness analyses. A case study of omalizumab efficacy and effectiveness for cost-effectiveness analysis evidence
Jonathan D Campbell, R Brett McQueen, Andrew Briggs
JAMA Pediatrics
|
March 20, 2018
Considerations for Cost-effectiveness Analysis of Curative Pediatric Therapies
Melanie D Whittington, R Brett McQueen, Jonathan D Campbell
Page
of 7
Search research articles
Search
Showing results (1-10 of 68) with videos related to
Sort By:
Page
of 7
Journal of General Internal Medicine
|
May 24, 2015
Capsule Commentary on Duru et al., Adherence to Metformin, Statins, and ACE/ARBs Within the Diabetes Health Plan (DHP)
R Brett McQueen
Pharmacoeconomics
|
May 16, 2020
What Value Does the NCCN Affordability Rating Really Provide to Patients, Providers, and Society?
R Brett McQueen
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 15, 2025
Should Early-Stage NIH Funding Influence Pharmaceutical Drug Pricing?
William V Padula, R Brett McQueen
Applied Health Economics and Health Policy
|
October 6, 2019
Expanding the Role of the Patient-Centered Outcomes Research Institute: Reauthorization and Facilitating Value Assessments
William V Padula, R Brett McQueen
Pharmacoeconomics
|
March 24, 2021
Toward Modified Impact Inventory Tables to Facilitate Patient-Centered Value Assessment
R Brett McQueen, Julia F Slejko
Pharmacotherapy
|
March 8, 2013
Clinical and financial impact of pharmacy services in the intensive care unit: pharmacist and prescriber perceptions
Robert MacLaren, R Brett McQueen, Jon Campbell
Diabetes Care
|
February 20, 2026
Deep Learning-Enabled Diabetic Retinopathy Screening: A Techno-Clinical Revolution or Just More Artificial Intelligence Hype?
Darpit Dave, Steven R Steinhubl, R Brett McQueen
Journal of Managed Care & Specialty Pharmacy
|
January 19, 2024
Assessing clinical benefit in the Medicare Drug Price Negotiation Program: A 2-step approach for improving transparency, consistency, and meaningful patient engagement
Michael J DiStefano, Antal Zemplenyi, R Brett McQueen
Annals of the American Thoracic Society
|
February 25, 2014
The "e" in cost-effectiveness analyses. A case study of omalizumab efficacy and effectiveness for cost-effectiveness analysis evidence
Jonathan D Campbell, R Brett McQueen, Andrew Briggs
JAMA Pediatrics
|
March 20, 2018
Considerations for Cost-effectiveness Analysis of Curative Pediatric Therapies
Melanie D Whittington, R Brett McQueen, Jonathan D Campbell
Page
of 7